GALD — Galderma AG Share News
0.000.00%
Last trade - 00:00- CH₣40.44bn
- CH₣42.01bn
- $5.24bn
Skincare firm Galderma not expecting hit from MidEast turmoil (updated)
Galderma not expecting hit to its business from Middle East turmoil
Galderma gives better than expected 2026 guidance, shares rise
Brief: Galderma Says Nemluvio Shows Long-Term Control In Prurigo Nodularis Up To 3 Years
Brief: Galderma Announces Triple Approval Of Restylane Syringe
Swiss stocks - Factors to watch on February 16
Brief: Galderma Appoints Luigi La Corte as CFO
Brief: Galderma Announces U.S. FDA Acceptance Of Relabotulinumtoxina Biologics License Application Resubmission
Swiss stocks - Factors to watch on January 22
Brief: Galderma Says Arbitral Trubunal Confirmed Termination Of Partnership With Ipsen
Top of the Street: Leonardo, Ferrari, ASMI, tyre makers, staples
Brief: Galderma - New Published Data Confirms Nemluvio Can Rapidly Relieve Itch And Improve Sleep In As Early As Two Days In Both Atopic Dermatitis And Prurigo Nodularis
Europe Research Roundup: Centrica, IHG, Volvo Car
Swiss stocks - Factors to watch on December 12
Press Digest: Wall Street Journal - December 9
Europe Research Roundup: Auto1 Group, Roche Holding, Sanofi
Galderma shares gain as L'Oreal lifts stake to 20%
L'Oreal in deal to increase stake in Galderma to 20% (updated)
Brief: EQT Sells Shares In Galderma Group AG To L'oréal